Cutler Group LP Cytokinetics Inc Transaction History
Cutler Group LP
- $307 Million
- Q1 2024
A detailed history of Cutler Group LP transactions in Cytokinetics Inc stock. As of the latest transaction made, Cutler Group LP holds 603 shares of CYTK stock, worth $36,282. This represents 0.01% of its overall portfolio holdings.
Number of Shares
603
Previous 30,200
98.0%
Holding current value
$36,282
Previous $817,000
94.86%
% of portfolio
0.01%
Previous 0.07%
Shares
17 transactions
Others Institutions Holding CYTK
# of Institutions
371Shares Held
129MCall Options Held
3.62MPut Options Held
1.14M-
T. Rowe Price Investment Management, Inc. Baltimore, MD17.6MShares$1.06 Billion0.37% of portfolio
-
Black Rock Inc. New York, NY14.7MShares$883 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$721 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.83MShares$471 Million0.05% of portfolio
-
State Street Corp Boston, MA6.37MShares$383 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $5.66B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...